Flow Diverter Performance for the Treatment of Intracranial Aneurysms: An International Multicenter Comparative Study.

ABSTRACT:

Background

Current evidence comparing flow diverters (FDs) for the treatment of intracranial aneurysms is limited to single-arm head-to-head retrospective and prospective studies. Herein, we aimed to compare the efficacy and safety of four FDs for the treatment of intracranial aneurysms.

Methods

We performed a retrospective, multicenter international cohort study of adult patients treated with FDs (Pipeline embolization device, Surpass Streamline, Flow Redirection Endoluminal Device, and Silk) for intracranial aneurysms between 2015 and 2021. Efficacy was determined by aneurysm occlusion at final follow-up. Safety was determined by ischemic/hemorrhagic events and mortality. Secondary safety was assessed by technical complications. A mixed-effect multivariable ordinal and log

SUBMITTER: Vivanco-Suarez J 

PROVIDER: S-EPMC12778624 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature